| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |